These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 21820606

  • 1. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
    Wang ZX, Lu BB, Wang H, Cheng ZX, Yin YM.
    Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
    [Abstract] [Full Text] [Related]

  • 2. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.
    Wang DD, Yang SJ, Chen X, Shen HY, Luo LJ, Zhang XH, Zhong SL, Zhao JH, Tang JH.
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [Abstract] [Full Text] [Related]

  • 3. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Shen H, Wang D, Li L, Yang S, Chen X, Zhou S, Zhong S, Zhao J, Tang J.
    Gene; 2017 Jan 05; 596():110-118. PubMed ID: 27746366
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.
    Li XJ, Ji MH, Zhong SL, Zha QB, Xu JJ, Zhao JH, Tang JH.
    Arch Med Res; 2012 Oct 05; 43(7):514-21. PubMed ID: 23085450
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H, Li L, Yang S, Wang D, Zhong S, Zhao J, Tang J.
    Gene; 2016 Nov 15; 593(1):84-90. PubMed ID: 27523474
    [Abstract] [Full Text] [Related]

  • 6. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer.
    Chang L, Hu Z, Zhou Z, Zhang H.
    Cell Physiol Biochem; 2018 Nov 15; 48(1):16-28. PubMed ID: 30001527
    [Abstract] [Full Text] [Related]

  • 7. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S, Li W, Chen Z, Xu J, Zhao J.
    Gene; 2013 Nov 15; 531(1):8-14. PubMed ID: 23994196
    [Abstract] [Full Text] [Related]

  • 8. [miR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1].
    Li X, Zhao J, Tang J.
    Zhonghua Zhong Liu Za Zhi; 2014 Dec 15; 36(12):892-6. PubMed ID: 25623761
    [Abstract] [Full Text] [Related]

  • 9. miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.
    Wang DD, Li J, Sha HH, Chen X, Yang SJ, Shen HY, Zhong SL, Zhao JH, Tang JH.
    Gene; 2016 Sep 15; 590(1):44-50. PubMed ID: 27282281
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
    Xie M, Fu Z, Cao J, Liu Y, Wu J, Li Q, Chen Y.
    Biomed Pharmacother; 2018 Jun 15; 102():286-294. PubMed ID: 29567542
    [Abstract] [Full Text] [Related]

  • 11. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J, Xia K, Xu P, Sun E, Ma J, Gao S, Zhou Q, Zhang M, Wang F, Chen F, Zhou P, Fu Z, Xie H.
    Biomed Pharmacother; 2014 Oct 15; 68(8):935-42. PubMed ID: 25451164
    [Abstract] [Full Text] [Related]

  • 12. Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.
    Hu D, Li M, Su J, Miao K, Qiu X.
    Genet Test Mol Biomarkers; 2019 Mar 15; 23(3):156-165. PubMed ID: 30807260
    [Abstract] [Full Text] [Related]

  • 13. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling.
    Chen Y, Sun Y, Chen L, Xu X, Zhang X, Wang B, Min L, Liu W.
    Mol Med Rep; 2013 May 15; 7(5):1579-84. PubMed ID: 23546450
    [Abstract] [Full Text] [Related]

  • 14. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
    Kang Y, Park MA, Heo SW, Park SY, Kang KW, Park PH, Kim JA.
    Biochim Biophys Acta; 2013 Mar 15; 1830(3):2638-48. PubMed ID: 23246576
    [Abstract] [Full Text] [Related]

  • 15. [Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR].
    Cui XY, Guo YJ, Yao HR.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct 15; 28(10):1813-5. PubMed ID: 18971180
    [Abstract] [Full Text] [Related]

  • 16. The function role of miR-181a in chemosensitivity to adriamycin by targeting Bcl-2 in low-invasive breast cancer cells.
    Zhu Y, Wu J, Li S, Ma R, Cao H, Ji M, Jing C, Tang J.
    Cell Physiol Biochem; 2013 Oct 15; 32(5):1225-37. PubMed ID: 24335172
    [Abstract] [Full Text] [Related]

  • 17. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
    Zhang J, Zhang HD, Yao YF, Zhong SL, Zhao JH, Tang JH.
    Cell Physiol Biochem; 2015 Oct 15; 36(6):2274-86. PubMed ID: 26279432
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
    Sun FD, Wang PC, Luan RL, Zou SH, Du X.
    Eur Rev Med Pharmacol Sci; 2018 Mar 15; 22(5):1342-1350. PubMed ID: 29565492
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D.
    J Cell Biochem; 2013 Aug 15; 114(8):1890-900. PubMed ID: 23494858
    [Abstract] [Full Text] [Related]

  • 20. Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway.
    Huang Q, Wu YY, Xing SJ, Yu ZW.
    Eur Rev Med Pharmacol Sci; 2019 Jun 15; 23(12):5285-5292. PubMed ID: 31298380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.